Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07481383
What this trial is testing

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
Continuity Biosciences, LLC 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07825753
What this trial is testing

Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer

Who this might be right for
Advanced or Metastatic Pancreatic AdenocarcinomaAdvanced or Metastatic Breast Cancer (BC)
Fudan University 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT01824875
What this trial is testing

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+4 more
ECOG-ACRIN Cancer Research Group 144
Not applicableLooking for participantsNCT04291651
What this trial is testing

UCSF PANC Cyst Registry

Who this might be right for
Pancreatic CystPancreatic NeoplasmsPancreatic Cancer+5 more
University of California, San Francisco 4,000
Large-scale testing (Phase 3)Study completedNCT00058201
What this trial is testing

Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Liverpool University Hospital 1,030
Not applicableStudy completedNCT01699698
What this trial is testing

Pancreatic Juice Diagnosis From Duodenum

Who this might be right for
Pancreatic Adenocarcinoma
Olympus Corporation 105
Not applicableUnknownNCT04435067
What this trial is testing

Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)

Who this might be right for
Pancreas Adenocarcinoma
IRCCS San Raffaele 44
Not applicableLooking for participantsNCT07328607
What this trial is testing

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

Who this might be right for
Pancreatic Ductal AdenocarcinomaAmpullary CarcinomaDistal Cholangiocarcinoma+2 more
Minia University 90
Large-scale testing (Phase 3)Study completedNCT00064207
What this trial is testing

Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 97
Not applicableStudy completedNCT04851106
What this trial is testing

Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.

Who this might be right for
Pancreas Cancer
GCS Ramsay Santé pour l'Enseignement et la Recherche 130
Testing effectiveness (Phase 2)Looking for participantsNCT07702292
What this trial is testing

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer (GC)+2 more
Blue Earth Diagnostics 71
Not applicableUnknownNCT05964621
What this trial is testing

Venous Thromboembolism in Primary Pancreatic Tumour Resection

Who this might be right for
Venous ThromboembolismPancreatic CancerPancreatic Ductal Adenocarcinoma
University of Thessaly 64
Testing effectiveness (Phase 2)Ended earlyNCT01096732
What this trial is testing

Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Lisa Bax 3
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Early research (Phase 1)Study completedNCT02174887
What this trial is testing

Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Institut Paoli-Calmettes 19
Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Early research (Phase 1)Study completedNCT00804336
What this trial is testing

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 22
Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Not applicableStudy completedNCT04802993
What this trial is testing

Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Linkoeping University 5,123
Early research (Phase 1)Ended earlyNCT02468557
What this trial is testing

Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Previously Untreated Pancreatic Ductal AdenocarcinomaRelapsed/Refractory Pancreatic Ductal Adenocarcinoma
Gilead Sciences 16
Next Page